Team:Groningen/Template/MODULE/Notebook/toolbox/week4
From 2014.igem.org
(Difference between revisions)
(One intermediate revision not shown) | |||
Line 21: | Line 21: | ||
The CP promoters in pSB1C3, that were isolated in the week | The CP promoters in pSB1C3, that were isolated in the week | ||
of 14 - 20 July, were tested on their insert size. For this, a PCR | of 14 - 20 July, were tested on their insert size. For this, a PCR | ||
- | was done on the plasmid using the primers | + | was done on the plasmid using the primers <a href="http://parts.igem.org/Part:BBa_G00100">VF2</a> and <a href="http://parts.igem.org/Part:BBa_G00101">VR</a>. |
- | + | The insert size corresponded to the expected size. | |
- | size. | + | |
</div> | </div> | ||
<div class="hspacer"> </div> | <div class="hspacer"> </div> | ||
Line 43: | Line 42: | ||
<!-- PARAGRAPH SNIPPET END--> | <!-- PARAGRAPH SNIPPET END--> | ||
+ | |||
+ | <!-- FIGURE SNIPPET START --> | ||
+ | </html>{{:Team:Groningen/Template/MODULE/newfigure|Figure 1|5/5f/Figure1notebooktoolbox.png| | ||
+ | Amplification of PNisI with RBS, NisA and sfGFP(Bs), with an added prefix and suffix. | ||
+ | }}<html> | ||
+ | <!-- FIGURE SNIPPET END--> | ||
<!-- PARAGRAPH SNIPPET START--> | <!-- PARAGRAPH SNIPPET START--> | ||
Line 71: | Line 76: | ||
<!-- PARAGRAPH SNIPPET END--> | <!-- PARAGRAPH SNIPPET END--> | ||
+ | |||
+ | <!-- FIGURE SNIPPET START --> | ||
+ | </html>{{:Team:Groningen/Template/MODULE/newfigure|Figure 2|b/b4/Figure2notebooktoolbox.png| | ||
+ | At the left: purified NisA, PNisI and sfGFP(Bs). At the right: NisA and sfGFP(Bs) after restriction with EcoRI and PstI. | ||
+ | }}<html> | ||
+ | <!-- FIGURE SNIPPET END--> | ||
<div class="hspacer"> </div> | <div class="hspacer"> </div> |
Latest revision as of 09:28, 17 October 2014
28 July - 3 August
The CP promoters in pSB1C3, that were isolated in the week
of 14 - 20 July, were tested on their insert size. For this, a PCR
was done on the plasmid using the primers VF2 and VR.
The insert size corresponded to the expected size.
A touchdown PCR was done on the genes of the nisin operon and the
sfGFP(Bs) gene. In this PCR the annealing temperature dropped from 55 °C to
45 °C, lowering the temperature with 1 °C each cycle. This
unfortunately resulted in a PCR program of just 10 cycles, instead of
the intended 30. The remaining steps of the program were finished the
next morning. Only the genes NisA, PNisI and sfGFP(Bs) were amplified
this way, see figure 1. Therefore, the PCR
was repeated, this time with a complete cycle. No additional genes
were amplified this way.
Another attempt was made for amplification of the remaining genes.
This time, the most ideal annealing temperature for each gene was
used by using a gradient PCR and placing the tubes at the optimal
temperature. This still did not amplify the remaining genes. Also, a
PCR with a general annealing temperature of 50 °C was done. This also
did not amplify the remaining genes.
The genes that were amplified in the first PCR (NisA, PNisI and sfGFP(Bs))
were purified using the GeneJET PCR Purification Kit from Thermo
Scientific. The purified products were digested with the enzymes EcoRI
and PstI, using 2 μl of the product. These purified and restricted
products were loaded on gel, see figure 2. It was then discovered that the genes were
barely visible on gel. The restricted genes were purified with the
GeneJET PCR Purification Kit and the concentration was measured with the
NanoDrop 1000. The clean, restricted products were too low in
concentration to be suitable for ligation.